Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

CD44 Regulates Formation of Spheroids and Controls Organ-Specific Metastatic Colonization in Epithelial Ovarian Carcinoma.

Sacks Suarez J, Gurler Main H, Muralidhar GG, Elfituri O, Xu HL, Kajdacsy-Balla AA, Barbolina MV.

Mol Cancer Res. 2019 May 30. doi: 10.1158/1541-7786.MCR-18-1205. [Epub ahead of print]

PMID:
31147393
2.

A fully automated, faster noise rejection approach to increasing the analytical capability of chemical imaging for digital histopathology.

Gupta S, Mittal S, Kajdacsy-Balla A, Bhargava R, Bajaj C.

PLoS One. 2019 Apr 24;14(4):e0205219. doi: 10.1371/journal.pone.0205219. eCollection 2019.

3.

Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids.

Richards Z, McCray T, Marsili J, Zenner ML, Manlucu JT, Garcia J, Kajdacsy-Balla A, Murray M, Voisine C, Murphy AB, Abdulkadir SA, Prins GS, Nonn L.

iScience. 2019 Feb 22;12:304-317. doi: 10.1016/j.isci.2019.01.028. Epub 2019 Jan 23.

4.

Physiologic serum 1,25 dihydroxyvitamin D is inversely associated with prostatic Ki67 staining in a diverse sample of radical prostatectomy patients.

Rosenberg A, Nettey OS, Gogana P, Sheikh U, Macias V, Kajdacsy-Balla A, Sharifi R, Kittles RA, Murphy AB.

Cancer Causes Control. 2019 Feb;30(2):207-214. doi: 10.1007/s10552-019-1128-2. Epub 2019 Feb 7.

PMID:
30730018
5.

Association of High miR-182 Levels with Low-Risk Prostate Cancer.

Baumann B, Acosta AM, Richards Z, Deaton R, Sapatynska A, Murphy A, Kajdacsy-Balla A, Gann PH, Nonn L.

Am J Pathol. 2019 Apr;189(4):911-923. doi: 10.1016/j.ajpath.2018.12.014. Epub 2019 Jan 29.

6.

Tissue spatial correlation as cancer marker.

Takabayashi M, Majeed H, Kajdacsy-Balla A, Popescu G.

J Biomed Opt. 2019 Jan;24(1):1-6. doi: 10.1117/1.JBO.24.1.016502.

PMID:
30666854
7.

GPX1 Localizes to the Nucleus in Prostate Epithelium and its Levels are not Associated with Prostate Cancer Recurrence.

Ekoue DN, Ansong E, Hong LK, Nonn L, Macias V, Deaton R, Rupnow R, Gann PH, Kajdacsy-Balla A, Diamond AM.

Antioxidants (Basel). 2018 Nov 18;7(11). pii: E167. doi: 10.3390/antiox7110167.

8.

Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.

Nettey OS, Walker AJ, Keeter MK, Singal A, Nugooru A, Martin IK, Ruden M, Gogana P, Dixon MA, Osuma T, Hollowell CMP, Sharifi R, Sekosan M, Yang X, Catalona WJ, Kajdacsy-Balla A, Macias V, Kittles RA, Murphy AB.

Urol Oncol. 2018 Nov;36(11):501.e1-501.e8. doi: 10.1016/j.urolonc.2018.06.011. Epub 2018 Sep 17.

9.

Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.

Acosta AM, Vormittag E, Al Rasheed MRH, Sharif A, Mon KS, Kajdacsy-Balla A, Mohapatra G.

Pathol Res Pract. 2018 Oct;214(10):1681-1685. doi: 10.1016/j.prp.2018.08.030. Epub 2018 Aug 29.

PMID:
30195638
10.

Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology.

Mittal S, Yeh K, Leslie LS, Kenkel S, Kajdacsy-Balla A, Bhargava R.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5651-E5660. doi: 10.1073/pnas.1719551115. Epub 2018 Jun 4.

11.

Label-free quantitative evaluation of breast tissue using Spatial Light Interference Microscopy (SLIM).

Majeed H, Nguyen TH, Kandel ME, Kajdacsy-Balla A, Popescu G.

Sci Rep. 2018 May 2;8(1):6875. doi: 10.1038/s41598-018-25261-7.

12.

Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.

Takabayashi M, Majeed H, Kajdacsy-Balla A, Popescu G.

PLoS One. 2018 Mar 21;13(3):e0194320. doi: 10.1371/journal.pone.0194320. eCollection 2018.

13.

Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.

Dasari S, Samy ALPA, Kajdacsy-Balla A, Bosland MC, Munirathinam G.

Food Chem Toxicol. 2018 May;115:218-227. doi: 10.1016/j.fct.2018.02.018. Epub 2018 Feb 9.

14.

A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.

Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov AV, Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A.

Cancer Res. 2018 Mar 15;78(6):1549-1560. doi: 10.1158/0008-5472.CAN-17-2106. Epub 2018 Jan 17.

15.

Predicting Fibrosis Progression in Renal Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging.

Varma VK, Kajdacsy-Balla A, Akkina S, Setty S, Walsh MJ.

Sci Rep. 2018 Jan 12;8(1):686. doi: 10.1038/s41598-017-19006-1.

16.

Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.

Ekoue DN, Ansong E, Liu L, Macias V, Deaton R, Lacher C, Picklo M, Nonn L, Gann PH, Kajdacsy-Balla A, Prins GS, Freeman VL, Diamond AM.

Prostate. 2018 Mar;78(4):279-288. doi: 10.1002/pros.23471. Epub 2018 Jan 5.

17.

Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis.

Vasavada SR, Dobbs RW, Kajdacsy-Balla AA, Abern MR, Moreira DM.

J Urol. 2018 May;199(5):1174-1181. doi: 10.1016/j.juro.2017.11.120. Epub 2017 Dec 12. Review.

PMID:
29246732
18.

Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease.

Acosta AM, Al Rasheed MRH, Rauscher GH, Vormittag E, Mon KS, Sharif A, Kajdacsy-Balla A, Mohapatra G.

Hum Pathol. 2018 May;75:1-9. doi: 10.1016/j.humpath.2017.11.015. Epub 2017 Nov 24.

PMID:
29180249
19.

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.

Wozniak DJ, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner ML, Bie W, Tyner AL.

Nat Commun. 2017 Nov 15;8(1):1508. doi: 10.1038/s41467-017-01574-5.

20.

Vitamin K and its analogs: Potential avenues for prostate cancer management.

Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, Kajdacsy-Balla A, Munirathinam G.

Oncotarget. 2017 May 19;8(34):57782-57799. doi: 10.18632/oncotarget.17997. eCollection 2017 Aug 22. Review.

Supplemental Content

Loading ...
Support Center